A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 3, 2014, Pages 1105-1116

  Matsushita, Takahiko ^a   Takada, Wataru ^b   Igarashi, Kota ^b   Naruchi, Kentaro ^c   Miyoshi, Risho ^c   Garcia Martin, Fayna ^a   Amano, Maho ^a,c   Hinou, Hiroshi ^a,c   Nishimura, Shin Ichiro ^a,c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Sumitomo Bakelite Co Ltd ^*  (Japan)

^c Hokkaido University and Medicinal Chemistry Pharmaceuticals LLC   (Japan)

Author keywords

Autoantibody; Epitope mapping; Microarray; MUC1 glycopeptide; Non specific protein adsorption

Indexed keywords

EPITOPE; GLYCOPEPTIDE; IMINE; IMMUNOGLOBULIN G ANTIBODY; KETONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DF3; MONOCLONAL ANTIBODY KL 6; MONOCLONAL ANTIBODY MA552; MONOCLONAL ANTIBODY MUC1; MONOCLONAL ANTIBODY SM3; MONOCLONAL ANTIBODY VU 11E2; MONOCLONAL ANTIBODY VU 12E1; MONOCLONAL ANTIBODY VU 3C6; MONOCLONAL ANTIBODY VU 3D1; MUCIN 1; PEPTIDE FRAGMENT; PHOSPHORYLCHOLINE; POLYMETHACRYLIC ACID; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MICROTECHNOLOGY; NORMAL HUMAN; PEPTIDE LIBRARY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN MICROARRAY; PROTEIN MOTIF; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; STANDARDIZATION; TANDEM REPEAT;

AUTOANTIBODY; EPITOPE MAPPING; MICROARRAY; MUC1 GLYCOPEPTIDE; NON-SPECIFIC PROTEIN ADSORPTION;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; EPITOPE MAPPING; HUMANS; MOLECULAR SEQUENCE DATA; MUCIN-1; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PROTEIN ARRAY ANALYSIS;

EID: 84890834542     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.11.009     Document Type: Article

References (102)

1. C.L. Hattrup, and S.J. Gendler Structure and function of the cell surface (tethered) mucins Annu. Rev. Physiol. 70 2008 431 457 (Pubitemid 351738187)
2. S. Bafna, S. Kaur, and S.K. Batra Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells Oncogene 29 2010 2893 2904
3. P. Mukherjee, A.R. Ginardi, C.S. Madsen, T.L. Tinder, F. Jacobs, J. Parker, B. Agrawal, B.M. Longenecker, and S.J. Gendler MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment Glycoconj. J. 18 2001 931 942 (Pubitemid 36315058)
4. M.A. Tarp, and H. Clausen Mucin-type O-glycosylation and its potential use in drug and vaccine development Biochim. Biophys. Acta 1780 2008 546 563 (Pubitemid 351381249)
5. M.A. Hollingsworth, and B.J. Swanson Mucins in cancer: protection and control of the cell surface Nat. Rev. Cancer 4 2004 45 60 (Pubitemid 38082153)
6. S. Schoonooghe, I. Burvenich, L. Vervoort, F. De Vos, N. Mertens, and J. Grooten PH1-derived bivalent bibodies and trivalent tribodies bind differentially to shed and tumour cell-associated MUC1 Protein Eng. Des. Sel. 23 2010 721 728
7. J. Taylor-Papadimitriou, J.A. Peterson, J. Arklie, J. Burchell, R.L. Ceriani, and W.F. Bodmer Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture Int. J. Cancer 28 1981 17 21 (Pubitemid 11070004)
8. M.D. Pegram, V.F. Borges, N. Ibrahim, J. Fulona, C. Perez Shapiro, K. Wang, F.S. Stark, and N.C. Luck Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer Breast Cancer Res. 11 2009 R73
9. B. Royer, W. Yin, M. Pegram, N. Ibrahim, C. Villanueva, D. Mir, F. Erlandsson, and X. Pivot Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer Br. J. Cancer 102 2010 827 832
10. N.K. Ibrahim, K.O. Yariz, I. Bondarenko, A. Manikhas, V. Semiglazov, A. Alyasova, V. Komisarenko, Y. Shaparyk, J.L. Murray, D. Jones, S. Sender, A. Chau, F. Erlandsson, G. Acton, and M. Pegram Randomized phase II trial of Letrozole plus anti-MUC1 antibody AS1402 in hormone receptor-positive locally advanced or metastatic breast cancer Clin. Cancer Res. 17 2011 6822 6830
11. A. Danielczyk, R. Stahn, D. Faulstich, A. Löffler, A. Märten, U. Karsten, and S. Goletz PankoMab: a potent new generation anti-tumour MUC1 antibody Cancer Immunol. Immunother. 55 2006 1337 1347 (Pubitemid 44187665)
12. X.N. Fan, U. Karsten, S. Goletz, and Y. Cao Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas Pathol. Res. Pract. 206 2010 585 589
13. D. Dian, M. Lenhard, D. Mayr, S. Heublein, U. Karsten, S. Goletz, C. Kuhn, I. Wiest, K. Friese, T. Weissenbacher, and U. Jeschke Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX (TM) detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8 Histol. Histopathol. 28 2013 239 244
14. M. Price, P. Rye, E. Petrakou, A. Murray, K. Brady, S. Imai, S. Haga, Y. Kiyozuka, D. Schol, and M. Meulenbroek Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin Tumour Biol. 19 1998 1
15. Y. Cao, and U. Karsten Binding patterns of 51 monoclonal antibodies to peptide and carbohydrate epitopes of the epithelial mucin (MUC1) on tissue sections of adenolymphomas of the parotid (Warthin's tumours): role of epitope masking by glycans Histochem. Cell Biol. 115 2001 349 356 (Pubitemid 32323892)
16. U. Karsten, C. Diotel, G. Klich, H. Paulsen, S. Goletz, S. Müller, and F. Hanisch Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation Cancer Res. 58 1998 2541
17. U. Karsten, N. Serttas, H. Paulsen, A. Danielczyk, and S. Goletz Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1) Glycobiology 14 2004 681
18. U. Karsten, S. von Mensdorff-Pouilly, and S. Goletz What makes MUC1 a tumor antigen Tumor Biol. 26 2005 217 220 (Pubitemid 41379749)
19. S. von Mensdorff-Pouilly, E. Petrakou, P. Kenemans, K. van Uffelen, A.A. Verstraeten, F.G. Snijdewint, G.J. van Kamp, D.J. Schol, C.A. Reis, M.R. Price, P.O. Livingston, and J. Hilgers Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides Int. J. Cancer 86 2000 702 712 (Pubitemid 30249883)
20. V. Karanikas, L.A. Hwang, J. Pearson, C.S. Ong, V. Apostolopoulos, H. Vaughan, P.X. Xing, G. Jamieson, G. Pietersz, B. Tait, R. Broadbent, G. Thynne, and I.F. McKenzie Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein J. Clin. Invest. 100 1997 2783 2792 (Pubitemid 28007547)
21. G.J. Rowse, R.M. Tempero, M.L. VanLith, M.A. Hollingsworth, and S.J. Gendler Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model Cancer Res. 58 1998 315 321 (Pubitemid 28047073)
22. S. Adluri, T. Gilewski, S. Zhang, V. Ramnath, G. Ragupathi, and P. Livingston Specificity analysis of sera from breast cancer patients vaccinated with MUC1-KLH plus QS-21 Br. J. Cancer 79 1999 1806
23. T. Gilewski, S. Adluri, G. Ragupathi, S. Zhang, T.J. Yao, K. Panageas, M. Moynahan, A. Houghton, L. Norton, and P.O. Livingston Vaccination of high-risk breast cancer patients with Mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21 Clin. Cancer Res. 6 2000 1693 1701 (Pubitemid 30305061)
24. M. Soares, V. Mehta, and O. Finn Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection J. Immunol. 166 2001 6555 6563 (Pubitemid 32467194)
25. C. Butts, N. Murray, A. Maksymiuk, G. Goss, E. Marshall, D. Soulières, Y. Cormier, P. Ellis, A. Price, and R. Sawhney Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer J. Clin. Oncol. 23 2005 6674 6681 (Pubitemid 46190262)
26. G. Ragupathi, L. Howard, S. Cappello, R.R. Koganty, D. Qiu, B.M. Longenecker, M.A. Reddish, K.O. Lloyd, and P.O. Livingston Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane- 1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells Cancer Immunol. Immunother. 48 1999 1 8 (Pubitemid 29197237)
27. E. Kagan, G. Ragupathi, S.S. Yi, C.A. Reis, J. Gildersleeve, D. Kahne, H. Clausen, S.J. Danishefsky, and P.O. Livingston Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn Cancer Immunol. Immunother. 54 2005 424 430 (Pubitemid 40543682)
28. S. Julien, G. Picco, R. Sewell, A.-S. Vercoutter-Edouart, M. Tarp, D. Miles, H. Clausen, J. Taylor-Papadimitriou, and J.M. Burchell Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model Br. J. Cancer 100 2009 1746 1754
29. V. Lakshminarayanan, P. Thompson, M.A. Wolfert, T. Buskas, J.M. Bradley, L.B. Pathangey, C.S. Madsen, P.A. Cohen, S.J. Gendler, and G.-J. Boons Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine Proc. Natl. Acad. Sci. U. S. A. 109 2012 261 266
30. R.E. Beatson, J.T. Papadimitriou, and J.M. Burchell MUC1 immunotherapy Immunotherapy 2 2010 305 327
31. H.H. Wandall, O. Blixt, M.A. Tarp, J.W. Pedersen, E.P. Bennet, U. Mandel, G. Ragupathi, P.O. Livingston, M.A. Hollingsworth, J. Taylor-Papadimitriou, J. Burchell, and H. Clausen Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes Cancer Res. 70 2010 1306 1313
32. J.W. Pedersen, O. Blixt, E.P. Bennet, M.A. Tarp, I. Dar, U. Mandel, S.S. Poulsen, A.E. Pedersen, S. Rasmussen, P. Jess, H. Clausen, and H.H. Wandall Seromic profiling of colorectal cancer patients with novel glycopeptide microarray Int. J. Cancer 128 2010 1860 1871
33. O. Blixt, D. Bueti, B. Burford, D. Allen, S. Julien, M. Hollingsworth, A. Gammerman, I. Fentiman, J. Taylor-Papadimitriou, and J.M. Burchell Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis Breast Cancer Res. 13 2011 R25
34. X. Wang, J. Yu, A. Sreekumar, S. Varambally, R. Shen, D. Gracheno, R. Mehra, J.E. Montie, K.J. Pienta, M.G. Sanda, P.W. Kantoff, M.A. Rubin, J.T. Wei, D. Ghosh, and A.M. Chinnaiyan Autoantibody signatures in prostate cancer N. Engl. J. Med. 353 2005 1224 1235 (Pubitemid 41345944)
35. H.T. Tan, J. Low, S.G. Lim, and M.C.M. Chung Serum autoantibodies as biomarkers for early cancer detection FEBS J. 276 2009 6880 6904
36. J. Hilkens, V. Kroezen, J.M. Bonfrer, M. De Jong-Bakker, and P.F. Bruning Clinical and epidemiological investigations - Articles: MAM-6 antigen, a new serum marker for breast cancer monitoring Cancer Res. 46 1986 2582 2587 (Pubitemid 16120735)
37. Q. Davies, A.C. Perkins, M. Frier, S. Watson, E.N. Lalani, and E.M. Symonds The effect of circulating antigen on the biodistribution of the engineered human antibody hCTM01 in a nude mice model Eur. J. Nucl. Med. 24 1997 206 209 (Pubitemid 27121102)
38. J. Taylor-Papadimitriou, and A.A. Epenetos Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy Trends Biotechnol. 12 1994 227 233 (Pubitemid 24190550)
39. R.C. Bast Jr., P. Ravdin, D.F. Hayes, S. Bates, H. Fritsche Jr., J.M. Jessup, N. Kemeny, G.Y. Locker, R.G. Mennel, and M.R. Somerfield 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology J. Clin. Oncol. 19 2001 1865 1878 (Pubitemid 32230890)
40. O.P. Kallioniemi, H. Oksa, R.K. Aaran, T. Hietanen, M. Lehtinen, and T. Koivula Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer Br. J. Cancer 58 1988 213 215
41. R. Colomer, A. Ruibal, Salvador Genolla, and L. Circulating CA 15-3 antigen levels in non-mammary malignancies Br. J. Cancer 59 1989 283 286 (Pubitemid 19072734)
42. V. Engelstaedter, S. Heublein, A.L. Schumacher, M. Lenhard, H. Engelstaedter, U. Andergassen, M.G. Biller, B. Kuhn, B. Rack, M. Kupka, D. Mayr, and U. Jeschke Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients BMC Cancer 12 2012 600
43. J.C. Cabrera-Abreu, W.S.A. Smellie, R. Bowley, and N. Shaw Best practice in primary care pathology J. Clin. Pathol. 65 2012 97 100
44. D. Kufe, G. Inghirami, M. Abe, D. Hayes, H. Justi-Wheeler, and J. Schlom Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors Hybridoma 3 1984 223 232 (Pubitemid 15184701)
45. J. Hilkens, F. Buijs, J. Hilgers, P. Hageman, J. Calafat, A. Sonnenberg, and M. van der Valk Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors Int. J. Cancer 34 1984 197 206 (Pubitemid 14053141)
46. L. Perey, D.F. Hayes, P. Maimonis, M. Abe, C. O'Hara, and D.W. Kufe Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen Cancer Res. 52 1992 2563 2568
47. N. Kohno, M. Akiyama, S. Kyoizumi, M. Hakoda, K. Kobuke, and M. Yamakido Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma Jpn. J. Clin. Oncol. 18 1988 203 216
48. C. Hermans, and A. Bernard Lung epithelium-specific proteins - characteristics and potential applications as markers Am. J. Respir. Crit. Care Med. 159 1999 646 678
49. N. Ohyabu, H. Hinou, T. Matsushita, R. Izumi, H. Shimizu, K. Kawamoto, Y. Numata, H. Togame, H. Takemoto, H. Kondo, and S.-I. Nishimura An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library J. Am. Chem. Soc. 131 2009 17102 17109
50. Y. Ogawa, T. Ishikawa, K. Ikeda, B. Nakada, T. Sawada, K. Ogisawa, Y. Kato, and K. Hirasawa Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer Clin. Cancer Res. 6 2000 4069 4072
51. a oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma Int. J. Cancer 120 2007 2643 2649 (Pubitemid 46651286)
52. N. Ishikawa, N. Hattori, A. Yokoyama, S. Tanaka, R. Nishino, K. Yoshikawa, S. Ohshimo, K. Fujitaka, H. Ohnishi, H. Hamada, K. Arihiro, and N. Kohno Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors Int. J. Cancer 122 2008 2612 2620 (Pubitemid 351590499)
53. Y. Fujiwara, K. Kiura, S. Toyooka, K. Hotta, M. Tabata, N. Takigawa, J. Soh, Y. Tanimoto, A. Kanehiro, K. Kato, H. Date, and M. Tanimoto Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinib Lung Cancer 59 2008 81 87
54. W. Zhang, W. Tang, Y. Inagaki, M. Qiu, H. Lixu, X. Li, Y. Sugawara, H. Sagawa, M. Nakata, and N. Kokudo Positive KL-6 mucin expression combined with decreased membranous B-catenin expression indicates worse prognosis in colorectal carcinoma Oncol. Rep. 20 2008 1013 1019
55. C.D. Rillahan, and J.C. Paulson Glycan microarrays for decoding the glycome Annu. Rev. Biochem. 80 2011 797 823
56. O. Blixt, I. Boos, and U. Mandel Glycan Microarray Analysis of Tumor-Associated Antibodies in Anticarbohydrate Antibodies P. Kosma, S. Müller-Loennies, 2011 Springer-Verlag Wien 283 306
57. C.-C. Wang, Y.-L. Huang, C.-T. Ren, J.-T. Hung, J.-C. Yu, A.L. Yu, C.-Y. Wu, and C.-H. Wong Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer Proc. Natl. Acad. Sci. U. S. A. 105 2008 11661 11666
58. O. Oyelaran, L.M. MeShane, D. Farnsworth, and J.C. Gildersleeve Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies J. Proteome Res. 8 2009 3529 3538
59. O. Oyelaran, L.M. MeShane, L. Dodd, and J.C. Gildersleeve Profiling human serum antibodies with a carbohydrate antigen microarray J. Proteome Res. 8 2009 4301 4310
60. M.E. Huflejt, M. Vuskovic, D. Vasiliu, H. Xu, P. Obukhova, N. Shilova, A. Tuzikov, B. Arun, K. Lu, and N. Bovin Anti-carbohydrate antibodies of normal sera: findings, surprises and challenges Mol. Immunol. 46 2009 3037 3049
61. O. Blixt, E. Clo, A.S. Nudekman, K.K. Sorensen, T. Clausen, H.H. Wandall, P.O. Livingston, H. Clausen, and K.J. Jensen A high throughput O-glycopeptide discovery platform for seromic profiling J. Proteome Res. 9 2010 5250 5261
62. S.-I. Nishimura, K. Niikura, M. Kurogochi, T. Matsushita, M. Fumoto, H. Hinou, R. Kamitani, H. Nakagawa, K. Deguchi, N. Miura, K. Monde, and H. Kondo High-Throughput protein glycomics: combined use of chemoselective glycoblotting and MALDI-TOF/TOF mass spectrometry Angew. Chem. Int. Ed. 44 2005 91 96 (Pubitemid 40069852)
63. T. Matsushita, H. Hinou, M. Fumoto, M. Kurogochi, N. Fujitani, H. Shimizu, and S.-I. Nishimura Construction of highly glycosylated mucin-type glycopeptides based on microwave-assisted solid-phase syntheses and enzymatic modifications J. Org. Chem. 71 2006 3051 3063
64. K. Naruchi, T. Hamamoto, M. Kurogochi, H. Hinou, H. Shimizu, T. Matsushita, N. Fujitani, H. Kondo, and S.-I. Nishimura Construction and structural characterization of versatile lactosaminoglycan-related compound library for the synthesis of complex glycopeptides and glycosphingolipids J. Org. Chem. 71 2006 9609 9621 (Pubitemid 46032625)
65. Nishimura, S-I. and Shimaoka, H. (2005) WO Patent WO/2005/097,844.
66. Matsumoto, T., Fukushima, M., Kuramoto, H., Fujiwara, K., and Funaoka, S. (2007) Patent JP2007-326920.
67. M. Fumoto, H. Hinou, T. Ohta, T. Ito, K. Yamada, A. Takimoto, H. Kondo, H. Shimizu, T. Inazu, Y. Nakahara, and S.-I. Nishimura Combinatorial synthesis of MUC1 glycopeptides: polymer blotting facilitates chemical and enzymatic synthesis of highly complicated mucin glycopeptides J. Am. Chem. Soc. 127 2005 11804 11818 (Pubitemid 41208766)
68. T. Matsushita, R. Sadamoto, N. Ohyabu, H. Nakata, H. Fumoto, N. Fujitani, Y. Takegawa, T. Sakamoto, M. Kurogochi, H. Hinou, H. Shimizu, T. Ito, K. Naruchi, H. Togame, H. Takemoto, H. Kondo, and S-I. Nishimura Functional neoglycopeptides: synthesis and characterization of a new class of MUC1 glycoprotein models having core 2-based O-glycan and complex-type N-glycan chains Biochemistry 48 2009 11117 11133
69. K.H. Shimizu, K. Hosoguchi, Y. Liu, N. Fujitani, T. Ohta, H. Hinou, T. Matsushita, H. Shimizu, T. Feizi, and S.-I. Nishimura Chemical synthesis, folding, and structural insights into O-fucosylated epidermal growth factor-like repeat 12 of mouse notch-1 receptor J. Am. Chem. Soc. 132 2010 14857 14865
70. M.-L. Lesaicherre, M. Uttamchandani, G.Y.J. Chen, and S.Q. Yao Developing site-specific immobilization strategies of peptides in a microarray Bioorg. Med. Chem. Lett. 12 2002 2079 2083 (Pubitemid 34804370)
71. O. Blixt, S. Head, T. Mondala, C. Scanlan, M.E. Huflejt, R. Alvarez, M.C. Bryan, F. Fazio, D. Calarese, J. Stevens, N. Razi, D.J. Stevens, J.J. Skehel, I. van Die, D.R. Burton, I.A. Wilson, R. Cummings, N. Bovin, C.-H. Wong, and J.C. Paulson Printed covalent glycan array for ligand profiling of diverse glycan binding proteins Proc. Natl. Acad. Sci. U. S. A. 101 2004 17033 17038 (Pubitemid 39627769)
72. E. Arigi, O. Blixt, K. Buschard, H. Clausen, and S.B. Levery Design of a covalently bonded glycosphingolipid microarray Glycoconj. J. 29 2012 1 12
73. G. Pirri, F. Damin, M. Chiari, E. Bontempi, and L.E. Depero Characterization of a polymeric adsorbed coating for DNA microarray glass slides Anal. Chem. 76 2004 1352 1358 (Pubitemid 38280483)
74. M. Fumoto, H. Hinou, T. Matsushita, M. Kurogochi, T. Ohta, T. Ito, K. Yamada, A. Takimoto, H. Kondo, T. Inazu, and S.-I. Nishimura Molecular transporter between polymer platforms: highly efficient chemoenzymatic glycopeptide synthesis by the combined use of solid-phase and water-soluble polymer supports Angew. Chem. Int. Ed. Engl. 44 2005 2534 2537 (Pubitemid 40600323)
75. T. Matsushita, I. Nagashima, M. Fumoto, T. Ohta, K. Yamada, H. Shimizu, H. Hinou, K. Naruchi, T. Ito, H. Kondo, and S.-I. Nishimura Artificial golgi apparatus: globular protein-like dendrimer facilitates fully automated enzymatic glycan synthesis J. Am. Chem. Soc. 132 2010 16651 16656
76. N. Nagahori, M. Abe, and S.-I. Nishimura Structural and functional glycosphingolipidomics by glycoblotting with an aminooxy-functionalized gold nanoparticle Biochemistry 48 2009 583 594
77. N. Nagahori, T. Yamashita, M. Amano, and S.-I. Nishimura Effect of ganglioside GM3 synthase gene knockout on the glycoprotein N-glycan profile of mouse embryonic fibroblast Chembiochem 14 2013 73 82
78. S.-I. Nishimura Toward automated glycan analysis Adv. Carbohydr. Chem. Biochem. 65 2011 219 271
79. R.E. Holmlin, X. Chen, R.G. Chapman, S. Takayama, and G.M. Whitesides Zwitterionic SAMs that resist nonspecific adsorption of protein from aqueous buffer Langmuir 17 2001 2841 2850 (Pubitemid 35330542)
80. S. Chen, J. Zheng, L. Li, and S. Jiang Strong resistance of phosphorylcholine self-assembled monolayers to protein adsorption: insights into nonfouling properties of zwitterionic materials J. Am. Chem. Soc. 127 2005 14473 14478 (Pubitemid 41457607)
81. T. Ohyanagi, N. Nagahori, K. Shimawaki, H. Hinou, T. Yamashita, A. Sasaki, T. Jin, T. Iwanaga, M. Kinjo, and S.-I. Nishimura Importance of sialic acid residues illuminated by live animal imaging using phosphorylcholine self-assembled monolayer-coated quantum dots J. Am. Chem. Soc. 133 2011 12507 12517
82. S.-I. Nishimura Phosphorylcholine self-assembled monolayers-coated quantum dots: real-time imaging of live animals by cell surface mimetic glyco-nanoparticles Clin. Lab. Med. 132 2012 73 87
83. K. Nouso, M. Amano, Y.M. Ito, K. Miyahara, Y. Morimoto, H. Kato, K. Tsutsumi, T. Tomoda, N. Yamamoto, S. Nakamura, S. Kobayashi, K. Kuwaki, H. Hagihara, H. Onishi, Y. Miyake, F. Ikeda, H. Shiraha, A. Takaki, T. Nakahara, S.-I. Nishimura, and K. Yamamoto Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer J. Gastroenterol. 48 2013 1171 1179
84. T. Kamiyama, H. Yokoo, J. Furukawa, M. Kurogochi, T. Togashi, N. Miura, K. Nakanishi, H. Kamachi, T. Kakisaka, Y. Tsuruga, M. Fujiyoshi, A. Takemoto, S.-I. Nishimura, and S. Todo Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis Hepatology 57 2013 2314 2325
85. K. Miyahara, K. Nouso, Y. Miyake, S. Nakamura, S. Obi, M. Amano, K. Hirose, S.-I. Nishimura, and K. Yamamoto Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib Hepatology 2013 10.1002/hep.26531 (in press)
86. M.A. Tarp, A.L. Sorensen, U. Mandel, H. Paulsen, J. Burchell, J. Taylor-Papadimitriou, and H. Clausen Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat Glycobiology 17 2007 197 209 (Pubitemid 46152536)
87. D.M. Coltart, A.K. Royyuru, L.J. Williams, P.W. Glunz, D. Sames, S.D. Kuduk, J.B. Schwarz, X.-T. Chen, S.J. Danishefsky, and D.H. Live Principles of mucin architecture: structural studies on synthetic glycopeptides bearing clustered mono-, di-, tri-, and hexasaccharide glycodomains J. Am. Chem. Soc. 124 2002 9833 9844
88. Y. Tachibana, G.L. Fletcher, N. Fujitani, S. Tsuda, K. Monde, and S.-I. Nishimura Antifreeze glycoproteins: elucidation of the structural motifs that are essential for antifreeze activity Angew. Chem. Int. Ed. 43 2004 856 862 (Pubitemid 39256214)
89. F. Corzana, J.H. Busto, G.J. Osés, M.G. de Luis, J.L. Asensio, J.J. Barbero, J.M. Peregrina, and A. Avenoza Serine versus threonine glycosylation: the methyl group causes a drastic alteration on the carbohydrate orientation and on the surrounding water shell J. Am. Chem. Soc. 129 2006 9458 9467 (Pubitemid 47218816)
90. R. Hashimoto, N. Fujitani, Y. Takegawa, M. Kurogochi, T. Matsushita, K. Naruchi, N. Ohyabu, H. Hinou, X.-D. Gao, N. Manri, H. Satake, A. Kaneko, T. Sakamoto, and S.-I. Nishimura An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides Chem. Eur. J. 17 2011 2393 2404
91. T. Matsushita, N. Ohyabu, N. Fujitani, K. Naruchi, H. Shimizu, H. Hinou, and S.-I. Nishimura Site-specific conformational alteration induced by sialylation of MUC1 tandem repeating glycopeptides at an epitope region for the anti-KL-6 monoclonal antibody Biochemistry 52 2013 402 414
92. S. Dziadek, C. Griesinger, H. Kunz, and U.M. Reinsheid Synthesis and structural model of an α(2,6)-sialyl-T glycosylated MUC1 eicosapeptide under physiological conditions Chem. Eur. J. 12 2006 4981 4993 (Pubitemid 43999118)
93. S.M. Amos, P.M. Duong, J.A. Westwood, D.S. Ritchie, R.P. Junghans, P.K. Darcy, and M.H. Kershaw Autoimmunity associated with immunotherapy of cancer Blood 118 2011 499 509
94. G.P. Dunn, A.T. Bruce, H. Ikeda, L.J. Old, and R.D. Schreiber Cancer immunoediting: from immunosurveillance to tumor escape Nat. Immunol. 3 2002 991 998 (Pubitemid 35363648)
95. G.P. Dunn, L.J. Old, and R.D. Screiber The three Es of cancer immunoediting Annu. Rev. Immunol. 22 2004 329 360 (Pubitemid 38680426)
96. L. Zitvogel, A. Tesniere, and G. Kroemer Cancer despite immunosurveillance: immunoselection and immunosubversion Nat. Rev. Immunol. 6 2006 715 727 (Pubitemid 44453458)
97. W.C. Hahn, and R.A. Weinberg Modelling the molecular circuitry of cancer Nat. Rev. Cancer 2 2002 331 341 (Pubitemid 37328946)
98. U. Westerlind, H. Schröder, A. Hobel, N. Gaidzik, A. Kaiser, C.M. Niemeyer, E. Schmitt, H. Waldmann, and H. Kunz Tumor-associated MUC1 tandem-repeat glycopeptide microarrays to evaluate serum- and monoclonal-antibody specificity Angew. Chem. Int. Ed. 48 2009 8263 8267
99. S. Tsuboi, M. Sutoh, S. Hatakeyama, N. Hiraoka, T. Habuchi, Y. Horikawa, Y. Hashimoto, T. Yoneyama, K. Mori, T. Koie, T. Nakamura, H. Saitoh, K. Yamaya, T. Funyu, M. Fukuda, and C. Ohyama A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans EMBO J. 30 2011 3173 3185
100. S. Müller, S. Goletz, N. Packer, A. Gooley, A.M. Lawson, and F.-G. Hanisch Localization of O-glycosylation sites on glycopeptide fragments from lactation-associated MUC1: all putative sites within the tandem repeat are glycosylation targets in vivo J. Biol. Chem. 272 1997 24780 24793 (Pubitemid 27415647)
101. S. Müller, and F.-G. Hanisch Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin: high density and prevalent core 2-based glycosylation J. Biol. Chem. 277 2002 26103 26112 (Pubitemid 34967094)
102. J.C. Manimala, T.A. Roach, Z. Li, and J.C. Gildersleeve High-throughput carbohydrate microarray profiling of 27 antibodies demonstrates widespread specificity problems Glycobiology 17 2007 17C 23C (Pubitemid 47241816)